GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
US Stock MarketDetailed Quotes
BEAM Beam Therapeutics
- 25.980
- -0.310-1.18%
Close Jan 24 16:00 ET
- 26.140
- +0.160+0.62%
Post 20:01 ET
2.15BMarket Cap-16.44P/E (TTM)
26.762High25.500Low622.19KVolume26.220Open26.290Pre Close16.21MTurnover0.91%Turnover RatioLossP/E (Static)82.81MShares49.50052wk High2.72P/B1.78BFloat Cap20.84052wk Low--Dividend TTM68.57MShs Float138.522Historical High--Div YieldTTM4.80%Amplitude13.000Historical Low26.059Avg Price1Lot Size
Trending Stocks
Discussing
Big Tech’s earnings season kicks off: How will market react?
🎙️ Discussion: 1. Can Big Tech earnings lead all sectors higher again? 2. How will the tech giants be affected by the "Trump Factor"?
Moomoo News Global
Jan 16 23:21
What You Need to Know Ahead of Big Tech Earnings
Beam Therapeutics Stock Forum
Beam Therapeutics Presents New Non-human Primate (NHP) Data Demonstrating Proof-of-concept for ESCAPE, a Non-genotoxic, Antibody-based Conditioning Approach to Treating Sickle Cell Disease, at American Society of Hematology (ASH) Annual Meeting
Beam Therapeutics (NASDAQ: BEAM) presented new data for its ESCAPE conditioning platform at the ASH Annual Meeting. The data demonstrated successful proof-of-concept in non-human primates (NHPs) for a non-genotoxic conditionin...
Sells🔴\\ $Zoom Communications (ZM.US)$ $Trimble (TRMB.US)$ $Twist Bioscience (TWST.US)$ $UiPath (PATH.US)$
• Editing Genes | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• Creating Therapies | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• Building DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• Dis...
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
"A turning point in medicine"
Scientists have made significant progress in treating thousands of illnesses over the years, but finding cures for rare and deadly diseases remains a significant challenge. While treatments for inherited conditions like sickle cell...
Dow Jones· 4 mins ago
No comment yet